BACKGROUND: It is unclear whether pandemic 2009 influenza A (pH1N1) infection caused more significant disease among hospitalized adults than seasonal influenza. METHODS: A prospective, observational study was conducted in adults hospitalized with polymerase chain reaction-confirmed pH1N1 infection in 2 acute-care general hospitals from June 2009 to May 2010 (n = 382). Complications and outcomes were described and compared with those in a seasonal influenza cohort (2007-2008, same hospitals; n = 754). RESULTS: Hospitalized patients with pH1N1 influenza were younger than those with seasonal influenza (mean age ± standard deviation, 47 ± 20 vs 70 ± 19 years) and fewer had comorbid conditions (48% vs 64%). The rate of positive immunofluorescence assay results was low (54% vs 84%), and antiviral use was frequent (96% vs 52%). Most patients in both cohorts developed complicated illnesses (67.8% vs 77.1%), but patients with pH1N1 influenza had higher rates of extrapulmonary complications (23% vs 16%; P = .004) and intensive care unit admission and/or death (patient age <35 years, 2.3% vs 0%; 35-65 years, 12.4% vs 3.2%; >65 years, 13.5% vs 8.5%; adjusted odds ratio [OR] 2.13; 95% confidence interval [CI], 1.25-3.62; P = .005). Patients who received antiviral treatment within 96 h after onset had better survival (log-rank test, P < .001). However, without timely treatment, the mortality risk was higher with pH1N1 infection (9.0% vs 5.8% for seasonal influenza; adjusted OR, 6.85; 95% CI, 1.64-28.65; P = .008]. Bacterial superinfection worsened outcomes. CONCLUSIONS: Adults hospitalized for pH1N1 influenza had significant complications and mortality despite being younger than patients with seasonal influenza. Antiviral treatment within 96 h may improve survival.
BACKGROUND: It is unclear whether pandemic 2009 influenza A (pH1N1) infection caused more significant disease among hospitalized adults than seasonal influenza. METHODS: A prospective, observational study was conducted in adults hospitalized with polymerase chain reaction-confirmed pH1N1 infection in 2 acute-care general hospitals from June 2009 to May 2010 (n = 382). Complications and outcomes were described and compared with those in a seasonal influenza cohort (2007-2008, same hospitals; n = 754). RESULTS: Hospitalized patients with pH1N1 influenza were younger than those with seasonal influenza (mean age ± standard deviation, 47 ± 20 vs 70 ± 19 years) and fewer had comorbid conditions (48% vs 64%). The rate of positive immunofluorescence assay results was low (54% vs 84%), and antiviral use was frequent (96% vs 52%). Most patients in both cohorts developed complicated illnesses (67.8% vs 77.1%), but patients with pH1N1 influenza had higher rates of extrapulmonary complications (23% vs 16%; P = .004) and intensive care unit admission and/or death (patient age <35 years, 2.3% vs 0%; 35-65 years, 12.4% vs 3.2%; >65 years, 13.5% vs 8.5%; adjusted odds ratio [OR] 2.13; 95% confidence interval [CI], 1.25-3.62; P = .005). Patients who received antiviral treatment within 96 h after onset had better survival (log-rank test, P < .001). However, without timely treatment, the mortality risk was higher with pH1N1 infection (9.0% vs 5.8% for seasonal influenza; adjusted OR, 6.85; 95% CI, 1.64-28.65; P = .008]. Bacterial superinfection worsened outcomes. CONCLUSIONS: Adults hospitalized for pH1N1 influenza had significant complications and mortality despite being younger than patients with seasonal influenza. Antiviral treatment within 96 h may improve survival.
Authors: Bárbara Borgatta; Marcos Pérez; J Rello; Loreto Vidaur; Leonardo Lorente; Lorenzo Socías; Juan Carlos Pozo; J C Pozo; José Garnacho-Montero; Jordi Rello Journal: Intensive Care Med Date: 2012-04-18 Impact factor: 17.440
Authors: Jessica Y Wong; Heath Kelly; Chung-Mei M Cheung; Eunice Y Shiu; Peng Wu; Michael Y Ni; Dennis K M Ip; Benjamin J Cowling Journal: Am J Epidemiol Date: 2015-07-18 Impact factor: 4.897
Authors: Trung Nguyen; Ursula G Kyle; Nancy Jaimon; M Hossein Tcharmtchi; Jorge A Coss-Bu; Fong Lam; Jun Teruya; Laura Loftis Journal: Crit Care Med Date: 2012-12 Impact factor: 7.598
Authors: Yi-Wei Tang; Kristin S Lowery; Alexandra Valsamakis; Virginia C Schaefer; James D Chappell; Jill White-Abell; Criziel D Quinn; Haijing Li; Cicely A Washington; Jenna Cromwell; Chantel M Giamanco; Michael Forman; Jeffery Holden; Richard E Rothman; Michelle L Parker; Elaine V Ortenberg; Lei Zhang; Yea-Lin Lin; Charlotte A Gaydos Journal: J Clin Microbiol Date: 2012-10-17 Impact factor: 5.948
Authors: S Bauernfeind; T Bruennler; B Ehrenstein; J Langgartner; J J Wenzel; S Werner; M Lubnow; T Mueller; B Floerchinger; B Salzberger Journal: Infection Date: 2012-08-11 Impact factor: 3.553